ATE443767T1 - Kostengünstige herstellung von peptiden - Google Patents

Kostengünstige herstellung von peptiden

Info

Publication number
ATE443767T1
ATE443767T1 AT03726398T AT03726398T ATE443767T1 AT E443767 T1 ATE443767 T1 AT E443767T1 AT 03726398 T AT03726398 T AT 03726398T AT 03726398 T AT03726398 T AT 03726398T AT E443767 T1 ATE443767 T1 AT E443767T1
Authority
AT
Austria
Prior art keywords
peptides
multimers
subject invention
amps
subject
Prior art date
Application number
AT03726398T
Other languages
English (en)
Inventor
Joseph Krebs
Paul Zorner
Ian Tomlinson
Original Assignee
Dow Global Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies Inc filed Critical Dow Global Technologies Inc
Application granted granted Critical
Publication of ATE443767T1 publication Critical patent/ATE443767T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/12—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by hydrolysis, i.e. solvolysis in general
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03726398T 2002-04-22 2003-04-22 Kostengünstige herstellung von peptiden ATE443767T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37464402P 2002-04-22 2002-04-22
PCT/US2003/012407 WO2003089455A2 (en) 2002-04-22 2003-04-22 Low-cost production of peptides

Publications (1)

Publication Number Publication Date
ATE443767T1 true ATE443767T1 (de) 2009-10-15

Family

ID=29251215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03726398T ATE443767T1 (de) 2002-04-22 2003-04-22 Kostengünstige herstellung von peptiden

Country Status (11)

Country Link
US (1) US7595173B2 (de)
EP (1) EP1501935B1 (de)
JP (1) JP4472998B2 (de)
KR (1) KR20050016362A (de)
CN (1) CN100489114C (de)
AT (1) ATE443767T1 (de)
AU (1) AU2003228637B2 (de)
CA (1) CA2482995C (de)
DE (1) DE60329382D1 (de)
IN (1) IN2004CH02621A (de)
WO (1) WO2003089455A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
WO2005052151A1 (en) 2003-11-19 2005-06-09 Dow Global Technologies Inc. Improved protein expression systems
US7985564B2 (en) 2003-11-21 2011-07-26 Pfenex, Inc. Expression systems with sec-system secretion
CN101151272A (zh) * 2003-12-01 2008-03-26 陶氏环球技术公司 在假单胞菌中生产重组二十面体病毒样颗粒
BRPI0506917A (pt) * 2004-01-16 2007-06-05 Dow Global Technologies Inc expressão de proteìnas de mamìferos em pseudomonas fluorescens
JP2007528727A (ja) 2004-02-27 2007-10-18 ザ　ダウ　ケミカル　カンパニー 植物細胞における高効率ペプチド生産
EP2412816B1 (de) 2004-07-26 2014-12-03 Pfenex Inc. Verfahren zur verbesserten Proteinexpression durch Strain-Engineering
US20080280781A1 (en) * 2005-01-16 2008-11-13 Georgia Tech Research Corporation Methods and Compositions for Increasing Membrane Permeability
EP2468869B1 (de) 2007-01-31 2015-03-18 Pfenex Inc. Bakterielle Leader-Sequenzen für erhöhte Expression
EP2615172A1 (de) 2007-04-27 2013-07-17 Pfenex Inc. Schnellscreeningverfahren für Bakterienwirte zur Identifizierung bestimmter Stämme mit verbessertem Ertrag und/oder verbesserter Qualität bei der Expression heterologer Proteine
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
WO2009076196A1 (en) 2007-12-07 2009-06-18 Dow Global Technologies Inc. High copy number self-replicating plasmids in pseudomonas
WO2009094634A1 (en) 2008-01-24 2009-07-30 Esperance Pharmaceuticals Lytic domain fusion constructs and methods of making and using same
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
MX2011012109A (es) * 2009-05-15 2012-01-27 Basf Se Composiciones farmaceuticas que contienen peptidos antimicoticos.
WO2010139736A2 (de) * 2009-06-03 2010-12-09 Basf Se Rekombinante herstellung von peptiden
EP2446028B1 (de) 2009-06-26 2018-04-04 Lysando Aktiengesellschaft Antimikrobielle wirkstoffe
PL2445515T3 (pl) 2009-06-26 2016-10-31 Środki przeciwdrobnoustrojowe
EP3401410B1 (de) 2010-06-26 2020-12-30 Virdia, Inc. Verfahren zur herstellung von zuckermischungen
US8609621B2 (en) 2010-11-15 2013-12-17 E I Du Pont De Nemours And Company Acid-cleavable linkers exhibiting altered rates of acid hydrolysis
KR102195193B1 (ko) 2012-03-09 2020-12-28 베스타론 코포레이션 독성 펩타이드 제조, 식물에서의 펩타이드 발현 및 시스테인 농후 펩타이드의 조합
US11692016B2 (en) 2012-03-09 2023-07-04 Vestaron Corporation High gene expression yeast strain
US9492563B2 (en) 2012-10-30 2016-11-15 Esperance Pharmaceuticals, Inc. Antibody/drug conjugates and methods of use
KR101830792B1 (ko) * 2016-01-27 2018-02-21 건국대학교 산학협력단 항균 펩타이드를 포함하는 불용성 융합단백질 및 이를 이용한 항균 펩타이드의 제조 방법
CN110267527A (zh) 2016-10-21 2019-09-20 韦斯塔隆公司 可切割肽及包含可切割肽的杀昆虫和杀线虫蛋白
JP2019002696A (ja) * 2017-06-12 2019-01-10 日本電子株式会社 質量分析データ処理装置、質量分析システム及び質量分析データ処理方法
WO2020206056A1 (en) 2019-04-04 2020-10-08 Greenvenus Llc Peptides and methods of plant protection
CN110305890A (zh) * 2019-07-02 2019-10-08 河南城建学院 一种新型5种抗菌肽串联表达重组工程菌构建方法及其应用
US20250042946A1 (en) 2021-12-08 2025-02-06 Oakgrove Bio Llc Biological Production of Histidine-Rich Peptides
CN115083176B (zh) * 2022-06-28 2024-05-10 浙江大学 一种基于多任务并行控制的网联自动车群串联排列实现方法
CN120882737A (zh) * 2023-02-23 2025-10-31 微肽技术有限公司 控制植物病原体的抗真菌肽
CN116333051A (zh) * 2023-03-09 2023-06-27 天津科技大学 一种抗菌肽改造体om19r原核表达制备方法及应用
WO2025093952A1 (en) * 2023-10-30 2025-05-08 Ramakrishna Reddy Isanaka Peptide with anti-inflammatory and anti-microbial activity

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2274344A (en) * 1939-01-06 1942-02-24 Kraft Cheese Company Package and method of making the same
GB1549167A (en) * 1975-04-11 1979-08-01 Takeda Chemical Industries Ltd Method for producing aminoglycosidec anitibiotics
US5206154A (en) * 1985-01-28 1993-04-27 Xoma Corporation Method of producing cecropins by microbiological techniques
US5861478A (en) * 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
ATE127838T1 (de) * 1987-07-06 1995-09-15 Univ Louisiana State Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden.
CA1327311C (en) * 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
US6132775A (en) * 1987-08-11 2000-10-17 New York University Therapeutic uses of biologically active bactericidal/permeability-increasing protein fragments
US5128130A (en) * 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) * 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
US4853334A (en) * 1988-04-27 1989-08-01 Microlife Technics, Inc. Method for the degradation of volatile chlorinated aliphatic hydrocarbons using pseudomonas fluorescens
JP2854872B2 (ja) 1989-02-02 1999-02-10 マルハ株式会社 カブトガニ血球膜由来抗菌性ペプタイドをリガンドとする不溶性担体
EP1004595B1 (de) 1989-04-10 2003-06-18 Helix BioMedix, Inc. Lytsche und proliferative Peptide und deren Verwendung als Pharmaka und Phytopharmaka
US5627262A (en) * 1989-07-05 1997-05-06 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5169760A (en) * 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
ATE118788T1 (de) * 1990-06-15 1995-03-15 Hoechst Schering Agrevo Gmbh Antifungisches polypeptid, verfahren zu seiner herstellung.
JPH07108232B2 (ja) * 1990-10-09 1995-11-22 エム・ディ・リサーチ株式会社 ペプチド又は蛋白質の製造方法
JP3523252B2 (ja) * 1990-11-21 2004-04-26 ホウテン ファーマシューティカルズ インコーポレイテッド 等モル多種オリゴマー混合物、特にオリゴペプチド混合物の合成
US5348742A (en) * 1991-05-24 1994-09-20 Ciba-Geigy Corporation Anti-pathogenic bacterial strains of Pseudomonas fluorescens
GB9115669D0 (en) 1991-07-19 1991-09-04 Sandoz Ltd Improvements in or relating to organic compounds
US5336757A (en) * 1992-02-07 1994-08-09 Harbor Branch Oceanographic Institution, Inc. Antibacterial peptide and methods of use
US5593866A (en) * 1992-08-21 1997-01-14 The University Of British Columbia Cationic peptides and method for production
US5789377A (en) * 1992-08-21 1998-08-04 University Of British Columbia Treatment of endotoxin-associated disorders with cationic peptides
US5496547A (en) * 1994-01-24 1996-03-05 Ciba-Geigy Corporation Pseudomonas biocontrol strains
US5527883A (en) * 1994-05-06 1996-06-18 Mycogen Corporation Delta-endotoxin expression in pseudomonas fluorescens
US5716849A (en) * 1994-06-08 1998-02-10 Novartis Finance Corporation Genes for the biosynthesis of soraphen
US5985617A (en) * 1997-02-18 1999-11-16 Liao; James C. Microorganisms and methods for overproduction of DAHP by cloned PPS gene
JPH08322556A (ja) * 1995-03-28 1996-12-10 Nisshin Flour Milling Co Ltd 新規なシュードモナス・フルオレッセンス
US5711945A (en) * 1995-05-11 1998-01-27 Regents Of The University Of Minnesota Pitch degradation with Pseudomonas fluorescens
US5944306A (en) * 1995-11-07 1999-08-31 Fuji Photo Film Co., Ltd. Package of thermal recording sheets and magazine
US5994306A (en) 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
EP0866804B1 (de) * 1995-12-16 2001-09-19 Planton GmbH, Gegen bakterien, mycota und viren wirksame vertebraten proteine und dessen kosmetische zubereitungen
AUPN861496A0 (en) 1996-03-13 1996-04-04 Commonwealth Scientific And Industrial Research Organisation Lytic peptides
US5851802A (en) * 1996-03-22 1998-12-22 Xoma Corporation Methods for recombinant microbial production of fusion proteins and BPI-derived peptides
DK0848064T3 (da) * 1996-12-13 2002-02-04 Hoechst Ag Nyt antibiotikum, feglymycin, fremgangsmåde til dets fremstilling og anvendelse
AU6035398A (en) 1997-01-31 1998-08-25 Incyte Pharmaceuticals, Inc. Human c5a-like receptor
KR100263583B1 (ko) * 1997-05-28 2000-08-01 박종헌 항균 펩타이드의 대량 제조방법 및 그에 유용한 플라즈미드 벡타
FR2766191B1 (fr) * 1997-07-21 2000-11-10 Ifremer Peptides anti-microbiens de crustaces
WO1999048912A1 (en) 1998-03-25 1999-09-30 Korea Advanced Institute Of Science And Technology A novel antimicrobial peptide isolated from parasilurus asotus and its uses
KR100319529B1 (ko) * 1998-06-09 2002-01-09 김일웅 펩타이드 항생물질의 대량 생산 방법 및 그에 유용한 유전자 구조물
US20020107174A1 (en) * 1998-07-02 2002-08-08 Erik J. Paus Composition comprising endotoxin neutralizing protein and derivatives and uses thereof
EP1131448A2 (de) * 1998-11-20 2001-09-12 Micrologix Biotech, Inc. Herstellung von kationischen antimikrobienpeptiden als fusionsproteinen
WO2000034312A1 (en) 1998-12-10 2000-06-15 Samyang Genex Corporation Method of separating basic peptide or basic protein
US6242219B1 (en) * 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
WO2003068948A1 (en) 2002-02-13 2003-08-21 Dow Global Technologies Inc. Over-expression of extremozyme genes in pseudomonads and closely related bacteria

Also Published As

Publication number Publication date
AU2003228637B2 (en) 2010-08-05
DE60329382D1 (de) 2009-11-05
IN2004CH02621A (en) 2007-03-02
US7595173B2 (en) 2009-09-29
CA2482995A1 (en) 2003-10-30
EP1501935A4 (de) 2007-05-23
JP2006504400A (ja) 2006-02-09
CA2482995C (en) 2013-01-29
US20050227321A1 (en) 2005-10-13
CN1662657A (zh) 2005-08-31
CN100489114C (zh) 2009-05-20
AU2003228637A1 (en) 2003-11-03
KR20050016362A (ko) 2005-02-21
WO2003089455A3 (en) 2004-05-27
WO2003089455A2 (en) 2003-10-30
JP4472998B2 (ja) 2010-06-02
EP1501935B1 (de) 2009-09-23
EP1501935A2 (de) 2005-02-02

Similar Documents

Publication Publication Date Title
ATE443767T1 (de) Kostengünstige herstellung von peptiden
EP1200124A4 (de) Immunglobulin fusionsproteine
DE69635452D1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
MX336118B (es) Expresion hibrida y en tandem de proteinas de neisseria.
SI1641483T1 (sl) Fuzijski proteini
AU2590901A (en) Il-17 homologous polypeptides and therapeutic uses thereof
WO2003020932A1 (en) Novel secretory proteins and dna thereof
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
DE60023860D1 (de) Verfahren zur herstellung von rekombinanten peptiden
WO2003062370A3 (en) Multimeric proteins and methods of making and using same
UA91820C2 (ru) Терапевтическое применение вариантов хемокинов
ATE211391T1 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
WO2006028561A3 (en) Novel purified fabi polypeptides from fransicella tularensis
CN101622269A (zh) 蛋白质在大肠杆菌中的表达
WO2003097789A3 (en) Farnesyl diphosphate synthase from pseudomonas aeruginosa
WO2004058810A3 (en) Crystal structures of nh3-dependent nad synthetases
WO2003087352A3 (en) Enolase polypeptides and structures
WO2004058811A3 (en) Crystal structures of yhhf polypeptides
WO2005005469A3 (en) Novel purified polypeptides from staphylococcus aureus
PL1646650T3 (pl) Układy do ekspresji rekombinowanego IGF
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
WO2004042045A3 (en) Crystal structures of bacterial thymidylate kinases
WO2004013167A3 (en) Purified polypeptides from enterococcus faecalis
WO2005058229A3 (en) Antiviral proteins with improved properties and methods therefor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties